🇺🇸 FDA
Patent

US 8557790

A3 adenoside receptor agonists for the reduction of intraocular pressure

granted A61KA61K31/00A61K31/7076

Quick answer

US patent 8557790 (A3 adenoside receptor agonists for the reduction of intraocular pressure) held by CAN-FITE BIOPHARMA LTD. expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAN-FITE BIOPHARMA LTD.
Grant date
Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/00, A61K31/7076, A61K9/2054, A61K9/4858